Skip to content

Effects of different volume treatment regimens on perioperative intestinal flora of patients undergoing pancreatic tumor surgery

Effects of different volume treatment regimens on perioperative intestinal flora of patients undergoing pancreatic tumor surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035187
Enrollment
Unknown
Registered
2020-08-02
Start date
2020-08-17
Completion date
Unknown
Last updated
2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

Group 1:adequate fluid supplementation
Group 2:GDFT

Sponsors

Department of Anesthesiology, Ruijin Hosptial affiliated to Shanghai Jiao Tong University School of Medician
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing pancreatic tumor surgery in this research center; 2. Aged >=18 years; 3. ASA level 1-2; 4. The patient had no serious complications of heart, lung and kidney diseases, and no serious metabolic diseases; 5. The patient was not preoperatively accompanied by intestinal obstruction, intestinal perforation, severe liver and kidney function injury and other diseases; PTCD, ENBD and other gastrointestinal operations were not performed; 6. Did not receive probiotic treatment within one year before surgery; No history of antibiotic use within 3 months before surgery.

Exclusion criteria

Exclusion criteria: 1. No stool samples were collected within 2 days before surgery and 6-8 days after surgery; 2. Unexpected secondary surgery patients before postoperative stool samples were collected; 3. Take laxative for intestinal preparation within 2 days before surgery; 4. Preoperative cardiac ultrasound examination of the patient showed LVEF < 50% and myocardial infarction occurred in the past three months; Lung function test FEV1 < 50%; Renal insufficiency, blood creatinine level exceeded the upper limit of normal value by 50%; 5. Preoperative infection, severe endocrine disease, severe blood system disease, nervous system disease, cerebrovascular disease history and mental disease; 6. Patients with severe allergies and short-term massive blood loss during the operation need to be rescued. 7. Patients who have concerns about this study and are unwilling to accept it.

Design outcomes

Primary

MeasureTime frame
Diversity of intestinal flora;

Secondary

MeasureTime frame
Intraoperative infusion volume;

Countries

China

Contacts

Public ContactLu Xiaojian

Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine

luxiaojian1989@163.com+86 13671623846

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 18, 2026